PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP)

CUSIP: 69353Y103

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / COMMON STOCK
Shares outstanding
53,185,766
Total 13F shares
46,465,983
Share change
-5,177,214
Total reported value
$144,025,863
Put/Call ratio
13%
Price per share
$3.10
Number of holders
97
Value change
-$52,160,467
Number of buys
55
Number of sells
56

Quarterly Holders Quick Answers

What is CUSIP 69353Y103?
CUSIP 69353Y103 identifies PMVP - PMV Pharmaceuticals, Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) as of Q4 2023

As of 31 Dec 2023, PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) was held by 97 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 46,465,983 shares. The largest 10 holders included ORBIMED ADVISORS LLC, JPMORGAN CHASE & CO, BlackRock Inc., ArrowMark Colorado Holdings LLC, Euclidean Capital LLC, VANGUARD GROUP INC, ALKEON CAPITAL MANAGEMENT LLC, Woodline Partners LP, Verition Fund Management LLC, and PFM Health Sciences, LP. This page lists 97 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.